Heron Therapeutics (HRTX) – Hot FDA News
-
Heron Therapeutics (HRTX) Announces U.S. FDA Approval of APONVIE for PONV
-
Heron Therapeutics (HRTX) Announces U.S. FDA Approval of ZYNRELEF for Management of Postoperative Pain for up to 72 Hours
-
-
-
-
-
-
-
-
Back to HRTX Stock Lookup